286 related articles for article (PubMed ID: 9614445)
1. Early stage nasopharyngeal carcinoma: radiotherapy dose and time factors in tumor control.
Chang JT; See LC; Liao CT; Chen LH; Leung WM; Chen SW; Chen WC
Jpn J Clin Oncol; 1998 Mar; 28(3):207-13. PubMed ID: 9614445
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
3. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; Wong CS; O SK
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1331-8. PubMed ID: 11121630
[TBL] [Abstract][Full Text] [Related]
4. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
[TBL] [Abstract][Full Text] [Related]
5. The role of brachytherapy in early-stage nasopharyngeal carcinoma.
Chang JT; See LC; Tang SG; Lee SP; Wang CC; Hong JH
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1019-24. PubMed ID: 8985022
[TBL] [Abstract][Full Text] [Related]
6. [Long-term efficacy of external radiotherapy plus intracavitary hyperfractionated brachytherapy on nasopharyngeal carcinoma].
Lin SJ; Pan JJ; Wu JX; Han L; Pan CZ
Ai Zheng; 2007 Feb; 26(2):208-11. PubMed ID: 17298755
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients.
Teo PM; Kwan WH; Yu P; Lee WY; Leung SF; Choi P
Clin Oncol (R Coll Radiol); 1996; 8(3):160-6. PubMed ID: 8814370
[TBL] [Abstract][Full Text] [Related]
8. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
Hwang JM; Fu KK; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1099-111. PubMed ID: 9719121
[TBL] [Abstract][Full Text] [Related]
9. Improved local control for early T-stage nasopharyngeal carcinoma--a tale of two hospitals.
Teo PM; Leung SF; Fowler J; Leung TW; Tung Y; O SK; Lee WY; Zee B
Radiother Oncol; 2000 Nov; 57(2):155-66. PubMed ID: 11054519
[TBL] [Abstract][Full Text] [Related]
10. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}.
Leung TW; Wong VY; Sze WK; Lui CM; Tung SY
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):361-7. PubMed ID: 17892917
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.
Chang JT; Lin CY; Chen TM; Kang CJ; Ng SH; Chen IH; Wang HM; Cheng AJ; Liao CT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1354-60. PubMed ID: 16297716
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control.
Sanguineti G; Geara FB; Garden AS; Tucker SL; Ang KK; Morrison WH; Peters LJ
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):985-96. PubMed ID: 9169804
[TBL] [Abstract][Full Text] [Related]
13. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
[TBL] [Abstract][Full Text] [Related]
14. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors.
Oksüz DC; Meral G; Uzel O; Cağatay P; Turkan S
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):388-94. PubMed ID: 15380570
[TBL] [Abstract][Full Text] [Related]
15. [Prospective study on long-term efficacy of external plus intracavitary radiotherapy on stage I-II nasopharyngeal carcinoma].
Cao XP; Lu TX; Ye WJ; Cui NJ
Ai Zheng; 2007 Feb; 26(2):204-7. PubMed ID: 17298754
[TBL] [Abstract][Full Text] [Related]
16. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose.
Teo PM; Leung SF; Lee WY; Zee B
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):445-58. PubMed ID: 10661353
[TBL] [Abstract][Full Text] [Related]
17. Brachytherapy boost for T1/T2 nasopharyngeal carcinoma.
Yeo R; Fong KW; Hee SW; Chua ET; Tan T; Wee J
Head Neck; 2009 Dec; 31(12):1610-8. PubMed ID: 19536853
[TBL] [Abstract][Full Text] [Related]
18. Addition of intracavitary brachytherapy to external beam radiation therapy for T1-T2 nasopharyngeal carcinoma.
Wu J; Guo Q; Lu JJ; Zhang C; Zhang X; Pan J; Tham IW
Brachytherapy; 2013; 12(5):479-86. PubMed ID: 23466362
[TBL] [Abstract][Full Text] [Related]
19. [Short-and long-term therapeutic effects of brachytherapy on intracavitary residual tumor in 563 nasopharyngeal carcinoma (NPC) patients].
Cao X; Chen K; He Z
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):146-7. PubMed ID: 10920969
[TBL] [Abstract][Full Text] [Related]
20. Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experience.
Lee N; Hoffman R; Phillips TL; Xia P; Quivey JM; Weinberg V; Hsu IC
Brachytherapy; 2002; 1(2):74-82. PubMed ID: 15062174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
